Philips buys catheter developer CardioProlific

2017 03 17 11 49 14 596 Philips Rsna 2016 Square

Royal Philips, the parent company of Philips Healthcare, said it has acquired CardioProlific, a U.S.-based firm that is developing catheter-based thrombectomy products to treat peripheral vascular disease. Terms of the deal were not disclosed.

CardioProlific's technologies are complementary to Philips' portfolio of image-guided therapy devices and to those of Spectranetics, another recent acquisition, according to Philips.

Philips said that CardioProlific's differentiated thrombectomy technologies, combined with its own image-guided therapy products, will advance innovation in the treatment of peripheral vascular disease.

Page 1 of 375
Next Page